INDBInternet News Database 2.5 Updated 2 min ago · 282 sources Show or hide images Light or dark

Results for “Drugmaker Novartis”

Health
1 source

Who is covering this

MedpagetodayCenter
Truth score 38
Centre 100%100%
MedpagetodayCenter

Gene Therapy Under Scrutiny After Nine Tumor Reports

(MedPage Today) -- Drugmaker Novartis acknowledged Thursday that there have been nine reports of tumors in children treated with its gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy (SMA). Two of the tumor...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Story Timeline
Like
Health
1 source

Who is covering this

ReutersCenter
Truth score 47
Centre 100%100%
ReutersCenter

AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say

AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say Reuters

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: CorporateOwner: Thomson Reuters
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Thomson Reuters100%
Avg reliability92
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 47 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 92 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Business
4 sources

Who is covering this

ReutersCenterThe HinduLeans leftNewsCenterLivemintCenter
Truth score 68
Left 33%33%Centre 67%67%
The HinduLeans left

India orders Sun Pharma to halt eye-care drug production at plant after quality lapses

Covered by 3 outlets: 1 lean left, 2 are centre.

Lean: Leans left Fact-focusedFactuality: HighCountry: IndiaFunding: PrivateOwner: The Hindu Group
Full coverage
Coverage breakdown
Funding
Corporate75%
Private25%
Countries
India75%
United Kingdom25%
Media ownership
Independent50%
Thomson Reuters25%
The Hindu Group25%
Avg reliability79
Low-credibility share0%
Fact / opinion4/0
State media0%
More analysis
Truth score: 68 (Corroborated) Propaganda risk: 0 Trending: Low Sources: 4 Reliability: 79 Bias severity: 0 Risk: 0Sentiment: -25Sensationalism: 4 Amplification: 0

How we score

Analyze: Story Timeline
Like